戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                                              ASGPR is composed of two highly homologous subunits, ter
2 ternary complex between a target protein and ASGPR on hepatocytes.
3 space around the well-known GalNAc-ligand as ASGPR-binder, a high-throughput screening campaign was p
4 dified siRNA has enabled asialoglycoprotein (ASGPR)-mediated targeted delivery of therapeutically act
5 rf1) of HuH-7 alters the asialoglycoprotein (ASGPR) and transferrin receptor subcellular distribution
6 rst X-ray crystal structures of ligand-bound ASGPR.
7                              In addition, DC-ASGPR ligation activated Akt, which differentially regul
8 uman primates with antigens fused to anti-DC-ASGPR monoclonal antibody generates antigen-specific CD4
9 hich provides a molecular explanation for DC-ASGPR-mediated programing of DCs to control host immune
10 gation of DC-asialoglycoprotein receptor (DC-ASGPR), a C-type lectin receptor (CLR) expressed on huma
11           DC-asialoglycoprotein receptor (DC-ASGPR), a lectinlike receptor, is a known scavenger rece
12         Our observations demonstrate that DC-ASGPR induces IL-10 expression via an intrinsic signalin
13 uding Dectin-1, signaling cascade through DC-ASGPR did not trigger NF-kappaB activation.
14  that targeting antigens to human DCs via DC-ASGPR, but not lectin-like oxidized-LDL receptor, Dectin
15 rgeting whole protein antigens to DCs via DC-ASGPR.
16 on experiments suggest that other endogenous ASGPR ligands, the nature of which remain to be determin
17 alactosamine (tri-GalNAc) motif that engages ASGPR to drive the downregulation of proteins.
18  designed ligands had similar affinities for ASGPR and similar silencing activity in mice as the pare
19  new ligands were obtained with affinity for ASGPR as good as or better than that of the parent N-ace
20       This molecule also exhibited increased ASGPR-directed hepatocellular uptake and prolonged reten
21 njugated ASOs showed high affinity for mouse ASGPR, which results in enhanced ASO delivery to hepatoc
22 r1-/- mice demonstrated that neither MGL nor ASGPR plays significant roles in regulating CHO-rVWF cle
23 s to biosynthesis and functional activity of ASGPR in vivo has remained controversial.
24  to make potent di- and trivalent binders of ASGPR.
25 ference in the kinetics of ER degradation of ASGPR H2a in susceptible as compared with protected host
26  hepatocytes or Hepa1 cell line), but not of ASGPR-negative 293 cells.
27 dase gene (LacZ) resulted in transduction of ASGPR-positive cells (rat hepatocytes or Hepa1 cell line
28  to express an unassembled membrane protein, ASGPR H2a.
29 the function of these compounds showed rapid ASGPR-dependent cellular uptake in vitro and high levels
30 raction with the asialoglycoprotein receptor ASGPR.
31  subunit of the asialoglycoprotein receptor (ASGPR H2a) were expressed in skin fibroblast cell lines
32  content of the asialoglycoprotein receptor (ASGPR) and three trafficking proteins, Rab3D, Rab7and Ra
33             The asialoglycoprotein receptor (ASGPR) is a high-capacity galactose-binding receptor exp
34   The mammalian asialoglycoprotein receptor (ASGPR) is located on the sinusoidal membrane of hepatocy
35  binding to the asialoglycoprotein receptor (ASGPR) on the surface of hepatocytes, facilitating liver
36 L) receptor and asialoglycoprotein receptor (ASGPR) was also significantly reduced.
37       Likewise, asialoglycoprotein receptor (ASGPR) was up-regulated in UCMSCs upon differentiation.
38 ins through the asialoglycoprotein receptor (ASGPR)), which mediate the degradation of extracellular
39 that engage the asialoglycoprotein receptor (ASGPR), a liver-specific lysosome-targeting receptor, to
40 tocyte-specific asialoglycoprotein receptor (ASGPR), enhances the potency of second-generation gapmer
41 tor (IGF2R) and asialoglycoprotein receptor (ASGPR), sortilin and transferrin receptors, and show tha
42 apical membrane asialoglycoprotein receptor (ASGPR), which is related to the ASGPR of liver cells.
43                 Asialoglycoprotein receptor (ASGPR)-mediated endocytosis has been used to target gene
44 cognized by the asialoglycoprotein receptor (ASGPR).
45 a case study of asialoglycoprotein receptor (ASGPR).
46  ligand for the asialoglycoprotein receptor (ASGPR).
47 ocyte-specific asialoglycoprotein receptors (ASGPR) to enhance uptake to hepatocytes and to increase
48 to disrupt the heterocomplex reduced surface ASGPR binding activity by 65 +/- 5.7%.
49 inent regression in tumor size confirmed the ASGPR-mediated uptake of ligand-anchored NCs and silenci
50 dependent sorting proteins from cytosol, the ASGPR cytoplasmic domain was expressed as a GST fusion p
51 internalized by HepG2 cells that express the ASGPR but were not taken up by HEK-293 cells that lack t
52  provide a hitherto unsuspected role for the ASGPR in transcriptional signaling, aside from its role
53 ng low-micromolar or better affinity for the ASGPR.
54 provide evidence that phosphorylation of the ASGPR cytoplasmic domain is required for the binding of
55 in receptor (ASGPR), which is related to the ASGPR of liver cells.
56 the absence of a change in TG binding to the ASGPR.
57 he coordination of the Ca(2+)-ion within the ASGPR-binding site by the cis-diol motif of the ribose u
58 ting glycoproteins are not elevated in these ASGPR-deficient mice.
59                       After the FPL binds to ASGPR on the hepatocyte surface, fusogenic activity of t
60  of HBV binding and uptake was observed when ASGPR was saturated with known specific ligands.